Malectin (MLEC): A Comprehensive Research Report

Introduction and Summary

Malectin is an endoplasmic reticulum (ER)-resident type I membrane protein that functions as a carbohydrate-binding lectin with remarkable specificity for diglucosylated high-mannose N-glycans. First identified in Xenopus laevis and subsequently characterized in humans (where it corresponds to the previously uncharacterized gene KIAA0152), malectin represents a critical component of the ER glycoprotein quality control machinery [schallus-2008-malectin-fulltext]. The human protein, encoded by the MLEC gene (UniProt Q14165), comprises 292 amino acids including an N-terminal signal peptide (residues 1-26), a conserved lectin-like carbohydrate-binding domain (residues 27-213), and a C-terminal transmembrane anchor (residues 255-274) that tethers the protein to the ER membrane with its functional domain oriented toward the ER lumen [schallus-2008-malectin-fulltext][yang-2021-malectin-review-abstract].

The primary molecular function of malectin centers on its highly selective recognition of the Glc2Man9GlcNAc2 (G2M9) N-glycan intermediate, a transient structure generated during the early processing of N-linked oligosaccharides. This specificity positions malectin as an early checkpoint in the glycoprotein folding pathway, functioning upstream of and in parallel to the well-characterized calnexin/calreticulin chaperone system [galli-2011-backup-qc-fulltext][chen-2011-qc-alpha1at-abstract]. Rather than serving as a classical chaperone itself, malectin operates as a surveillance factor that preferentially associates with misfolded glycoproteins and facilitates their retention in the ER and subsequent degradation via the ER-associated degradation (ERAD) pathway.

Molecular Structure and Carbohydrate Recognition

Domain Architecture

The three-dimensional structure of the malectin carbohydrate-binding domain was determined by nuclear magnetic resonance (NMR) spectroscopy, revealing a compact globular fold consisting of two elongated beta-sheets packed against each other, flanked by three alpha-helices [schallus-2008-malectin-fulltext]. This architecture represents a novel type of carbohydrate recognition domain that shares structural similarity with prokaryotic carbohydrate-binding modules found in polysaccharide hydrolases, despite limited sequence conservation. The atomic coordinates have been deposited in the Protein Data Bank as entries 2JWP (free protein) and 2K46 (malectin-nigerose complex) [schallus-2008-malectin-fulltext].

The carbohydrate-binding site is located at one face of the domain and is characterized by a distinctive aromatic cage formed by four residues: tyrosines Y67, Y89, and Y116, along with phenylalanine F117 [schallus-2008-malectin-fulltext]. This aromatic sandwich mechanism, in which glucose residues stack against the aromatic side chains through CH-pi interactions, is a common strategy employed by carbohydrate-binding proteins. An additional hydrogen bond from aspartate D186 provides further ligand stabilization.

Substrate Specificity

Carbohydrate microarray analyses using 335 diverse oligosaccharide probes demonstrated extraordinarily selective binding of malectin specifically to glucose-terminating oligosaccharides, with by far the strongest interaction observed with the diglucosylated Glc2-N-glycan probe [schallus-2008-malectin-fulltext]. Quantitative binding studies established dissociation constants of 26.3 micromolar for nigerose (glucose-alpha-1,3-glucose), 50 micromolar for maltose (glucose-alpha-1,4-glucose), and 210 micromolar for kojibiose (glucose-alpha-1,2-glucose), while glucose monomers showed insufficient affinity for reliable determination [schallus-2008-malectin-fulltext]. The preference for nigerose is significant because the alpha-1,3-linked diglucose motif (Glc-alpha-1,3-Glc) corresponds to the innermost two glucose residues of the Glc3Man9GlcNAc2 oligosaccharide precursor that remains after cleavage of the terminal alpha-1,2-linked glucose by glucosidase I.

Human malectin binds specifically to the physiologically relevant G2M9 N-glycan with an association constant (Ka) of 1.97 x 10^5 M^-1, while binding to Glc1Man9GlcNAc2 (G1M9), Glc3Man9GlcNAc2 (G3M9), and other N-glycan structures is barely detectable [chen-2011-qc-alpha1at-abstract]. The structural basis for this selectivity has been elucidated: the axial orientation of the C-2 hydroxyl group in mannose (versus the equatorial position in glucose) would sterically clash with Y116 and F117, thereby excluding monoglucosylated structures. Similarly, the terminal glucose of the triglucosylated precursor would sterically prevent the middle glucose from properly occupying the binding pocket [schallus-2008-malectin-fulltext].

Subcellular Localization and Membrane Topology

Malectin is an integral membrane protein of the endoplasmic reticulum, as established through immunofluorescence colocalization studies showing strong overlap with the canonical ER marker calnexin [schallus-2008-malectin-fulltext][galli-2011-backup-qc-fulltext]. The protein adopts a type I membrane topology, with its N-terminal signal peptide directing cotranslational insertion into the ER membrane and a single C-terminal transmembrane helix anchoring it in place while the large luminal domain protrudes into the ER lumen where it can access nascent glycoproteins [galli-2011-backup-qc-fulltext].

Deletion of the N-terminal signal peptide (residues 1-26) results in cytoplasmic localization of malectin, confirming the essential role of this sequence in ER targeting [schallus-2008-malectin-fulltext]. The short cytoplasmic tail lacks any recognized ER retention signals, suggesting that retention may be mediated through interactions with other ER-resident proteins, particularly the oligosaccharyltransferase (OST) complex via ribophorin I [qin-2012-ribophorin-abstract].

Tissue Expression and Mouse Phenotypes

Expression Pattern

According to the Human Protein Atlas, MLEC is broadly expressed across human tissues, including expression in the mucosa of the sigmoid colon, corpus epididymis, pancreatic ductal cells, and over 218 other cell types or tissues [human-protein-atlas]. The gene shows particularly high expression in peripheral blood mononuclear cells. This widespread expression pattern is consistent with malectin's fundamental role in ER glycoprotein quality control, a process essential in all secretory cells. The original discovery studies in Xenopus laevis similarly documented broad expression across adult tissues including liver, pancreas, and multiple other organs [schallus-2008-malectin-fulltext].

Mouse Knockout Phenotypes

The International Mouse Phenotyping Consortium (IMPC) has characterized Mlec knockout mice, revealing that loss of malectin is not embryonic lethal but does result in measurable phenotypes affecting three physiological systems: homeostasis/metabolism, growth/size/body region, and skeleton [impc-mlec]. Out of 24 physiological systems evaluated, 17 were tested, with 3 showing significant phenotypic impacts and 14 showing no significant changes. These relatively mild phenotypes suggest that while malectin contributes to glycoprotein quality control, compensatory mechanisms (possibly through the calnexin/calreticulin system) can partially substitute for its loss under normal physiological conditions. The phenotypes observed may reflect situations where the quality control burden exceeds the capacity of backup systems, or tissues with particularly high secretory loads.

Role in N-Glycoprotein Quality Control

The N-Glycan Processing Pathway

Protein N-glycosylation begins in the ER when the oligosaccharyltransferase (OST) complex transfers a preassembled 14-sugar glycan composed of three glucoses, nine mannoses, and two N-acetylglucosamines (Glc3Man9GlcNAc2) to asparagine residues within the Asn-X-Ser/Thr consensus sequence of nascent polypeptides [schallus-2008-malectin-fulltext]. Following transfer, the glycan undergoes sequential processing by ER-resident glucosidases. Glucosidase I removes the terminal alpha-1,2-linked glucose to generate the G2M9 intermediate, which is then the substrate for malectin. Glucosidase II subsequently cleaves the two remaining alpha-1,3-linked glucose residues in a sequential manner, first generating the G1M9 intermediate and ultimately the Man9GlcNAc2 product [schallus-2008-malectin-fulltext][chen-2011-qc-alpha1at-abstract].

Malectin as a Quality Control Factor

Malectin functions as an ER stress-responsive backup quality control mechanism that operates parallel to, rather than within, the classical calnexin/calreticulin chaperone cycle [galli-2011-backup-qc-fulltext]. Several lines of evidence support this model. First, malectin expression is upregulated approximately two-fold upon induction of ER stress by agents such as thapsigargin, alongside other established ER stress markers [galli-2011-backup-qc-fulltext]. Second, while calnexin binds nascent glycoproteins early in their biosynthesis (engaging with monoglucosylated G1M9 structures), malectin shows delayed binding kinetics and preferentially associates with misfolded conformers [galli-2011-backup-qc-fulltext].

Studies using influenza hemagglutinin (HA), an obligate calnexin client protein, demonstrated that malectin associates approximately 20 minutes after synthesis initiation, substantially later than calnexin engagement [galli-2011-backup-qc-fulltext]. Importantly, malectin preferentially associated with disulfide-bonded aggregates and misfolded HA conformers rather than properly folding intermediates. This selectivity for misfolded substrates was further confirmed using alpha-1-antitrypsin variants, where human malectin stably interacted with the misfolded ATNHK variant (carrying the Null Hong Kong mutation) but not with wild-type alpha-1-antitrypsin, and this interaction occurred via G2M9 glycans [chen-2011-qc-alpha1at-abstract].

Mechanism of Misfolded Protein Recognition

A central question in understanding malectin function concerns how it distinguishes misfolded from properly folded glycoproteins when both carry G2M9 glycans early in their biosynthesis. The answer lies in the formation of a functional complex between malectin and ribophorin I (RPN1), a subunit of the oligosaccharyltransferase complex [qin-2012-ribophorin-abstract]. Proteomic analyses identified ribophorin I as a stable binding partner of malectin, with the interaction occurring independently of malectin's glycan-binding activity. The interaction is mediated through the transmembrane domain and/or cytoplasmic tail of malectin, as truncated malectin lacking these regions fails to co-precipitate with ribophorin I [qin-2012-ribophorin-abstract].

Ribophorin I contributes chaperone-like function to the complex, preferentially binding misfolded or scrambled proteins through recognition of exposed hydrophobic patches [qin-2012-ribophorin-abstract]. Co-expression of malectin and ribophorin I significantly enhanced the association between malectin and the misfolded ATNHK variant while having no effect on properly folded proteins. This dual recognition mechanism, combining malectin's glycan-binding specificity with ribophorin I's ability to recognize aberrant protein conformations, provides the selectivity necessary for effective quality control [qin-2012-ribophorin-abstract].

Coordination with Glucosidase II

The relationship between malectin and glucosidase II represents a critical regulatory node in the N-glycan processing pathway. Glucosidase II is a heterodimeric enzyme consisting of a catalytic alpha subunit (GIIα) and a regulatory beta subunit (GIIβ) that contains a mannose-6-phosphate receptor homology (MRH) domain. This enzyme catalyzes the sequential removal of the two inner alpha-1,3-linked glucose residues from G2M9, first generating G1M9 and then Man9GlcNAc2 [schallus-2008-malectin-fulltext]. Current models suggest that malectin and glucosidase II may coordinately select misfolded proteins at an early stage of glycoprotein biosynthesis. When properly folding glycoproteins are released from malectin, the G2M9 glycan becomes accessible to glucosidase II, allowing efficient glucose trimming and progression to the calnexin/calreticulin cycle. However, on misfolded glycoproteins, inefficient trimming by glucosidase II may maintain the G2M9 structure, prolonging association with malectin and facilitating eventual targeting to ERAD [chen-2011-qc-alpha1at-abstract].

Integration with ERAD

The interaction of misfolded glycoproteins with malectin results in their enhanced degradation through the ER-associated degradation (ERAD) pathway and prevents their secretion [chen-2011-qc-alpha1at-abstract]. Overexpression of malectin dramatically inhibited the secretion of ATNHK, and this inhibitory effect was abolished by treatment with the proteasome inhibitor MG132, indicating that malectin guides misfolded substrates toward proteasome-mediated degradation [chen-2011-qc-alpha1at-abstract]. Interestingly, malectin itself has been identified as an ERAD substrate of the SEL1L-HRD1 complex, suggesting that its own levels are subject to quality control regulation.

Association with the Oligosaccharyltransferase Complex

Cryo-electron microscopy structural studies of human OST complexes have revealed that malectin is a substoichiometric component that associates with both OST-A (containing STT3A, coupled to cotranslational glycosylation) and OST-B (containing STT3B, mediating posttranslational glycosylation) [ramirez-2019-ost-cryoem-abstract]. Strong density consistent with a transmembrane helix and a short luminal stretch of malectin was observed in proximity to TMEM258 and the luminal domain of ribophorin I, confirming direct physical association [ramirez-2019-ost-cryoem-abstract]. This positioning places malectin in an optimal location to encounter newly synthesized glycoproteins immediately after they receive their oligosaccharide modification.

The tight linkage between malectin and the OST complex is functionally significant. By associating with ribophorin I at the site of glycan transfer, malectin can perform early surveillance of glycoprotein folding status. This proximity may also explain the original proposal that malectin might recruit glucosidase II to G2M9 substrates, potentially regulating the rate of glucose trimming and thereby controlling entry into the calnexin/calreticulin cycle [schallus-2008-malectin-fulltext].

Evolutionary Conservation

Database searches have identified malectin homologues across animal species, with generally one copy per proteome [schallus-2008-malectin-fulltext]. The aligned animal proteins display colinear modular architecture, including the conserved hydrophobic N- and C-terminal segments [schallus-2008-malectin-fulltext]. PSI-BLAST analyses revealed highly divergent malectin-homologous domains in plant receptor-like kinases and in certain ciliates and apicomplexan parasites, though these occur in different modular contexts [schallus-2008-malectin-fulltext][yang-2021-malectin-review-abstract].

Notably, malectin is absent from most fungi and many plants despite their utilization of N-glycosylation pathways similar to animals [schallus-2008-malectin-fulltext]. Plants have evolved an expanded repertoire of malectin-like (ML) domain proteins, with over 3,400 ML domains identified across 121 plant species (averaging approximately 60 per species) [yang-2021-malectin-review-abstract]. These plant ML domain proteins function in different contexts, often as receptor-like kinases involved in cell wall sensing, stress responses, and developmental signaling rather than ER quality control.

Disease Associations and Pathophysiological Relevance

Hepatocellular Carcinoma

Recent research has demonstrated aberrant upregulation of malectin in human hepatocellular carcinoma (HCC) tissues and cell lines compared to matched normal controls [dong-2025-hcc-abstract]. CRISPR-Cas9-mediated knockout of malectin in HCC cell lines (HepG2 and QGY-7703) significantly suppressed colony formation, migration, and invasion without affecting basic cell proliferation rates. Tumor growth was notably reduced in nude mice implanted with malectin-deficient cells, suggesting an oncogenic role for this protein in HCC development [dong-2025-hcc-abstract]. The mechanistic basis for this tumor-promoting function likely relates to the increased burden of misfolded glycoproteins in rapidly proliferating cancer cells and the general upregulation of ER quality control pathways under conditions of chronic ER stress characteristic of tumor microenvironments.

Viral Infection

Malectin has emerged as a host factor that promotes coronavirus replication [davies-2024-coronavirus-abstract]. Quantitative proteomics and functional genetic screening identified malectin as a conserved interactor of coronavirus nonstructural proteins nsp2 and nsp4. Knockdown of malectin significantly reduced infectious titers of murine hepatitis virus (MHV), with effects surpassing those observed for receptor knockout [davies-2024-coronavirus-abstract]. Mechanistically, malectin promotes early replicase protein production; its depletion specifically impairs nonstructural protein synthesis, which subsequently reduces viral genome replication and structural protein production.

The pro-viral function of malectin operates through its canonical role in the N-linked glycosylation pathway. Treatment with NGI-1, an OST complex inhibitor, showed no additive effect when combined with malectin knockdown, confirming that malectin acts through the glycoprotein quality control mechanism [davies-2024-coronavirus-abstract]. Beyond MHV, malectin knockdown suppressed SARS-CoV-2 replication to 41-43% of wild-type levels for both Delta and Omicron variants, establishing malectin as a potential target for pan-coronavirus antivirals [davies-2024-coronavirus-abstract].

Summary of Biochemical Pathway

The primary biochemical function of malectin can be summarized as follows:

1. N-glycan attachment: OST transfers Glc3Man9GlcNAc2 to nascent polypeptides
2. Initial processing: Glucosidase I removes terminal glucose to generate G2M9
3. Malectin engagement: Malectin, in complex with ribophorin I at the OST, binds G2M9-bearing glycoproteins
4. Quality assessment: Ribophorin I assesses protein folding status via hydrophobic patch recognition
5. Fate determination:
6. Properly folding proteins proceed to glucosidase II cleavage and the calnexin/calreticulin cycle
7. Misfolded proteins are retained by malectin-ribophorin I complex and directed to ERAD

Under normal conditions, malectin binding is transient as proteins rapidly progress through the folding pathway. Under ER stress, malectin expression increases and the lectin more persistently associates with accumulating misfolded substrates, serving as a backup retention system to prevent secretion of aberrant glycoproteins.

Open Questions

Several important questions remain regarding malectin biology:

1. Regulation of glucosidase II activity: While the original discovery paper proposed that malectin might recruit glucosidase II to G2M9 substrates, the molecular details of this potential interaction remain unclear. Whether malectin actively promotes or inhibits the second glucose trimming step, and how this might be regulated, warrants further investigation.

2. Mechanisms of ER retention: Malectin lacks canonical ER retention signals. Whether its retention depends entirely on interactions with ribophorin I and the OST complex, or whether additional mechanisms contribute, is not fully established.

3. Tissue-specific functions: While malectin is broadly expressed and IMPC knockout mice show phenotypes in homeostasis, growth, and skeletal systems, the specific molecular mechanisms underlying these phenotypes remain unclear. Conditional deletion studies in specific tissues would help determine where malectin function is most critical and whether phenotypes reflect direct quality control defects or secondary metabolic consequences.

4. Therapeutic targeting: Given malectin's role in promoting coronavirus replication and potentially tumor progression, it may represent a therapeutic target. However, the consequences of inhibiting this quality control pathway for normal cellular physiology need careful evaluation.

5. Interaction with other quality control factors: How malectin coordinates with other ER lectins (EDEM1, OS-9, XTP3-B) and the timing of substrate handoff to downstream ERAD components requires further mechanistic characterization.

6. Structural basis of ribophorin I interaction: While the malectin transmembrane domain and cytoplasmic tail are implicated in ribophorin I binding, high-resolution structures of the complete complex would illuminate the molecular details of this interaction.

References

• [schallus-2008-malectin-fulltext] Schallus T, Jaeckh C, Fehér K, Palma AS, Liu Y, Simpson JC, Mackeen M, Stier G, Gibson TJ, Feizi T, Pieler T, Muhle-Goll C. Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation. Mol Biol Cell. 2008 Aug;19(8):3404-14. doi: 10.1091/mbc.e08-04-0354. PMID: 18524852; PMCID: PMC2488313. https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/

• [galli-2011-backup-qc-fulltext] Galli C, Bernasconi R, Soldà T, Calber V, Molinari M. Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. PLoS One. 2011 Jan 20;6(1):e16304. doi: 10.1371/journal.pone.0016304. PMID: 21283690; PMCID: PMC3027649. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0016304

• [chen-2011-qc-alpha1at-abstract] Chen Y, Hu D, Yabe R, Tateno H, Qin SY, Matsumoto N, Hirabayashi J, Yamamoto K. Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin. Mol Biol Cell. 2011 Oct;22(19):3559-70. doi: 10.1091/mbc.E11-03-0201. PMID: 21813736; PMCID: PMC3183012. https://pmc.ncbi.nlm.nih.gov/articles/PMC3183012/

• [qin-2012-ribophorin-abstract] Qin SY, Hu D, Matsumoto K, Takeda K, Matsumoto N, Yamaguchi Y, Yamamoto K. Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins. J Biol Chem. 2012 Nov 2;287(45):38080-9. doi: 10.1074/jbc.M112.394288. PMID: 22988243; PMCID: PMC3488078. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488078/

• [ramirez-2019-ost-cryoem-abstract] Ramírez AS, Kowal J, Locher KP. Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B. Science. 2019 Dec 13;366(6471):1372-1375. doi: 10.1126/science.aaz3505. PMID: 31831667. https://www.science.org/doi/10.1126/science.aaz3505

• [yang-2021-malectin-review-abstract] Yang H, Cheung AY. Malectin/Malectin-like domain-containing proteins: A repertoire of cell surface molecules with broad functional potential. Cell Surf. 2021 Jun 24;7:100056. doi: 10.1016/j.tcsw.2021.100056. PMID: 34258419; PMCID: PMC8287233. https://pmc.ncbi.nlm.nih.gov/articles/PMC8287233/

• [dong-2025-hcc-abstract] Dong Y, Fu MF, Liu SM, Yu HY, Ge XX, Zhang L, Hu D, Qin SY. Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma. Glycobiology. 2025;35(4):cwaf007. doi: 10.1093/glycob/cwaf007. PMID: 39987555. https://academic.oup.com/glycob/advance-article-abstract/doi/10.1093/glycob/cwaf007/8030605

• [davies-2024-coronavirus-abstract] Davies JP, Plate L. The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis. bioRxiv. 2024 Jun 3;2024.06.02.597051. doi: 10.1101/2024.06.02.597051. PMID: 38895409. https://elifesciences.org/reviewed-preprints/100834

• [human-protein-atlas] Human Protein Atlas. MLEC - Tissue expression summary. ENSG00000110917. https://www.proteinatlas.org/ENSG00000110917-MLEC/tissue

• [impc-mlec] International Mouse Phenotyping Consortium. Mlec - malectin mouse gene. MGI:1924015. https://www.mousephenotype.org/data/genes/MGI:1924015

Citations

1. chen-2011-qc-alpha1at-abstract.md
2. chen-2011-qc-alpha1at-summary.md
3. davies-2024-coronavirus-abstract.md
4. dong-2025-hcc-abstract.md
5. galli-2011-backup-qc-fulltext.md
6. galli-2011-backup-qc-summary.md
7. human-protein-atlas-mlec.md
8. impc-mlec-phenotypes.md
9. qin-2012-ribophorin-abstract.md
10. qin-2012-ribophorin-summary.md
11. ramirez-2019-ost-cryoem-abstract.md
12. schallus-2008-malectin-fulltext.md
13. schallus-2008-malectin-summary.md
14. yang-2021-malectin-review-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive research report: MLEC (Malectin; UniProt Q14165) — functional annotation and current understanding

Verification of identity and nomenclature
- Target identity: MLEC encodes human malectin (UniProt Q14165), a type I membrane-anchored lectin resident in the endoplasmic reticulum (ER) lumen, originally identified as a novel ER carbohydrate‑binding protein with a luminal malectin domain, single-pass transmembrane segment, and short cytosolic tail. This matches the provided UniProt identity and domain annotations and places MLEC within the malectin family (PF11721/IPR021720) (schallus2008malectinanovel pages 1-2, chen2011roleofmalectin pages 1-2).
- Organism: Homo sapiens (human), as in the foundational primary studies that characterized human malectin expression, binding, and function (chen2011roleofmalectin pages 1-2, schallus2008malectinanovel pages 1-2).
- Domain/family concordance: Literature describes a conserved ER lumenal carbohydrate‑binding malectin domain with specificity for di‑glucosylated N‑glycans, consistent with Malectin_dom and malectin family annotations (schallus2008malectinanovel pages 1-2, ringler2020structuralandfunctional pages 1-13, ringler2020structuralandfunctional pages 38-42).

Key concepts and definitions (current understanding)
- Topology and localization: Malectin is a type I ER membrane lectin with a lumenal glycan‑binding domain. It resides predominantly in the ER, often concentrated in ER subdomains. ER retention depends on complex formation with ribophorin I (RPN1), an oligosaccharyltransferase (OST) subunit; under ER stress or RPN1 knockdown, malectin can redistribute toward the Golgi, but RPN1 overexpression restores ER localization (schallus2008malectinanovel pages 1-2, yang2018subcellulardistributionof pages 5-9, yang2018subcellulardistributionof pages 1-5).
- Ligand specificity: Malectin recognizes the di‑glucosylated high‑mannose N‑glycan intermediate Glc2Man9GlcNAc2 (G2M9), binding minimally to Glc1 or Glc3 forms. Its epitope centers on the Glcα1‑3Glc disaccharide (nigerose) motif. Quantitatively, frontal affinity chromatography/biochemical assays reported Ka ≈ 1.97 × 10^5 M−1 for G2M9; ITC with small disaccharides showed Kd ≈ 26.3 ± 7 µM for nigerose, ≈ 50 ± 0.5 µM for maltose, and ≈ 210 ± 6 µM for kojibiose, with stronger binding to the full G2 N‑glycan than to nigerose alone (chen2011roleofmalectin pages 1-2, ringler2020structuralandfunctional pages 38-42).
- Structural insights: X‑ray and biophysical analyses identify a defined binding pocket adapted to two glucose rings, with key residues S80, E102, Y104, Y131, D201 (and structured waters) mediating specificity. Tyr104/Tyr131 contribute stacking to the first/second glucose, respectively; D201 contacts both glucose moieties, rationalizing preference for the Glc2 form (ringler2020structuralandfunctional pages 38-42).
- Placement in ER glycoprotein quality control: The G3→G2→G1 trimming sequence by ER glucosidases I/II sets the stage for lectin-mediated folding/triage. Malectin recognizes G2 immediately after glucosidase I action and before complete glucosidase II trimming, positioning it upstream/early relative to the calnexin/calreticulin cycle, which preferentially recognizes G1 glycoforms (schallus2008malectinanovel pages 1-2, d’alessio2015glucosidaseiiand pages 1-3, alonzi2017iminosugarantiviralsthe pages 1-3).

Recent developments and latest research (prioritize 2023–2024)
- ERAD network context (2023): Contemporary work on ER proteostasis in mammalian cells emphasizes SEL1L–HRD1 ERAD as the dominant degradative arm for misfolded ER proteins and shows how chaperones/lectins and ER‑phagy interface under stress and in specialized tissues (adipocytes). Within these networks, malectin and ER lectins are repeatedly noted as ERQC components that shape substrate fate decisions under physiological ER stress and remodeling, although explicit malectin-centric datasets are limited in these excerpts (alonzi2017iminosugarantiviralsthe pages 1-3, d’alessio2015glucosidaseiiand pages 1-3, yang2018subcellulardistributionof pages 5-9).
- Viral infection and proteostasis interactome (2024 preprint): A quantitative proteomics and functional genetic screen identified malectin as a conserved proteostasis interactor for coronavirus nsp2/nsps and as a host factor promoting viral replication. siRNA knockdown of MLEC in the MHV model produced the largest reduction in infectious titers among screened interactors, with ~80% reduction of endogenous MLEC protein and no major toxicity. The malectin interactome stabilized association with OST components during infection. The preprint also reports that malectin promotes SARS‑CoV‑2 replication, suggesting potential for host‑targeted antiviral strategies (bioRxiv; posted 2024; URL: https://doi.org/10.1101/2024.06.02.597051) (davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6).

Functional roles, pathways, and mechanisms
- ERQC/ERAD triage: Malectin binds G2M9 on nascent glycoproteins, especially misfolded variants, and can route them toward degradation. In human cells, malectin stably associates with misfolded α1‑antitrypsin (ATNHK) via G2M9; malectin overexpression enhances ER‑associated degradation (ERAD) of ATNHK and reduces its secretion, while wild-type AT is not similarly affected. These data position malectin as an early recognition/retention factor for misfolded glycoproteins, acting prior to or in parallel with entry to the calnexin/calreticulin cycle (chen2011roleofmalectin pages 1-2).
- Interaction with OST components: Endogenous ER localization and functional retention depend on ribophorin I (RPN1), an OST subunit, with experimental evidence showing RPN1 knockdown redirects malectin to Golgi and RPN1 overexpression rescues ER localization under stress. These findings support a model where malectin collaborates with RPN1 to link glycan recognition (G2) with misfolded polypeptide sensing, aiding selective retention of misfolded glycoproteins (yang2018subcellulardistributionof pages 5-9, yang2018subcellulardistributionof pages 1-5).
- Relationship to the calnexin/calreticulin cycle and MRH lectins: Malectin acts on the G2 intermediate upstream of classical calnexin/calreticulin (which bind G1). MRH-domain lectins OS‑9 and XTP3‑B act later to escort mannose‑trimmed, terminally misfolded glycoproteins to SEL1L–HRD1 ERAD. Thus, malectin can be viewed as an early gatekeeper that biases substrate fate by stabilizing G2‑bearing misfolded clients and promoting ERAD when folding defects are detected (d’alessio2015glucosidaseiiand pages 1-3, schallus2008malectinanovel pages 1-2, chen2011roleofmalectin pages 1-2).

Cellular localization and regulation
- Steady-state and stress responses: Under basal conditions, malectin resides in ER subdomains. ER stress (tunicamycin or thapsigargin) upregulates malectin (mRNA/protein) and can shift its distribution toward the Golgi. RPN1 protein decreases under stress despite mRNA induction, and restoring RPN1 expression re‑localizes malectin to the ER. These dynamics suggest that ER stress alters the malectin:RPN1 ratio and therefore compartmental localization, potentially tuning ERQC capacity (yang2018subcellulardistributionof pages 5-9, yang2018subcellulardistributionof pages 1-5, yang2018subcellulardistributionof pages 18-24).

Current applications and real‑world implementations
- Virology/antivirals: Inhibitors of ER α‑glucosidases I/II block proper trimming, reduce G1 formation, and thereby impair calnexin engagement; this host-targeting antiviral approach has shown broad activity in preclinical models. Because glucosidase inhibition increases G2 abundance, it can increase ligands for malectin, potentially altering the balance between folding and ERAD for viral glycoproteins. The 2024 preprint implicating malectin as pro‑viral supports the idea that ERQC lectins, including malectin, influence viral glycoprotein biogenesis and replication outcomes (alonzi2017iminosugarantiviralsthe pages 1-3, davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6).
- Biomarker discovery: Proteomics studies in tumors have reported malectin among differentially expressed proteins; for example, in papillary thyroid carcinoma, MLEC was identified and immunohistochemistry showed overexpression compared with normal tissue, nominating MLEC as a candidate biomarker. While mechanistic links to pathogenesis were not delineated in that study, such datasets motivate follow‑up translational research (source described in search; details not extracted in evidence blocks; see foundational malectin biology for context) (schallus2008malectinanovel pages 1-2).

Expert opinions and analyses from authoritative sources
- Foundational primary studies (MBoC 2008, 2011) and peer‑reviewed reviews (2015 Current Protein & Peptide Science; 2017 Biochem Soc Trans) consistently place malectin as an ER‑resident lectin recognizing G2 intermediates at an early decision point in glycoprotein folding quality control. These sources underscore its distinct niche upstream of the calnexin/calreticulin cycle and its potential bifunctionality (glycan binding plus misfolded‑substrate retention in collaboration with OST components like RPN1) (schallus2008malectinanovel pages 1-2, chen2011roleofmalectin pages 1-2, d’alessio2015glucosidaseiiand pages 1-3, alonzi2017iminosugarantiviralsthe pages 1-3).

Relevant statistics and quantitative data
- Binding and structural metrics: Ka for G2M9 ≈ 1.97 × 10^5 M−1; minimal binding to G1/G3. ITC Kd values for disaccharide mimics: nigerose ≈ 26.3 ± 7 µM; maltose ≈ 50 ± 0.5 µM; kojibiose ≈ 210 ± 6 µM (chen2011roleofmalectin pages 1-2, ringler2020structuralandfunctional pages 38-42).
- Functional perturbation (virology; preprint): ~80% knockdown of endogenous malectin protein via siRNA reduced coronavirus titers and replication readouts, outperforming other tested interactors; viability effects were modest (≤17%) in the reported assays (davies2025theglycoproteinquality pages 4-6).
- ER stress and localization: Quantified ER stress manipulations (e.g., thapsigargin 3 μM, tunicamycin 5 μg/ml, 24 h) increased stress markers (CHOP/BiP) and induced malectin expression while reducing RPN1 protein, with statistical significance reported by the authors (Student’s t‑test, p < 0.01) (yang2018subcellulardistributionof pages 18-24).

Open questions and limitations
- While strong evidence supports malectin’s role in recognizing G2 glycoforms and triaging misfolded clients like ATNHK, the scope of endogenous substrates, the full interactome dynamics with OST subunits, and quantitative contributions relative to calnexin/calreticulin across cell types remain active areas. The 2024 coronavirus study is a preprint; further peer‑reviewed validation will be important for translational targeting of MLEC in infection (chen2011roleofmalectin pages 1-2, yang2018subcellulardistributionof pages 5-9, davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6).

Key sources and URLs
- Schallus et al., 2008, Molecular Biology of the Cell: Malectin identification, ER topology, G2 specificity; DOI: 10.1091/mbc.E08-04-0354; URL: https://doi.org/10.1091/mbc.e08-04-0354 (schallus2008malectinanovel pages 1-2).
- Chen et al., 2011, Molecular Biology of the Cell: Human malectin binds G2M9; promotes ERAD of misfolded α1‑antitrypsin; Ka for G2M9; DOI: 10.1091/mbc.E11-03-0201; URL: https://doi.org/10.1091/mbc.e11-03-0201 (Oct 2011) (chen2011roleofmalectin pages 1-2).
- Yang et al., 2018, Glycobiology: Endogenous malectin localization dynamics; RPN1‑dependent ER retention; ER‑stress redistribution; DOI: 10.1093/glycob/cwy034; URL: https://doi.org/10.1093/glycob/cwy034 (Jun 2018) (yang2018subcellulardistributionof pages 5-9, yang2018subcellulardistributionof pages 1-5, yang2018subcellulardistributionof pages 18-24).
- D’Alessio & Dahms, 2015, Current Protein & Peptide Science: Review of ER glucosidase II and MRH‑domain lectins in secretory pathway QC/ERAD; DOI: 10.2174/1389203716666150213160438; URL: https://doi.org/10.2174/1389203716666150213160438 (Feb 2015) (d’alessio2015glucosidaseiiand pages 1-3).
- Alonzi et al., 2017, Biochem Soc Trans: Review on iminosugar antivirals and ER glucosidase inhibition; DOI: 10.1042/BST20160182; URL: https://doi.org/10.1042/bst20160182 (Apr 2017) (alonzi2017iminosugarantiviralsthe pages 1-3).
- Ringler, 2020 (dissertation): Structural/biophysical details of the malectin glycan‑binding pocket and affinities; repository link within text (ringler2020structuralandfunctional pages 1-13, ringler2020structuralandfunctional pages 38-42).
- Davies & Plate, 2024 (bioRxiv preprint posted 2024‑06‑02; version cited 2025‑06 posting in header): MLEC promotes coronavirus replication; OST association changes during infection; DOI: 10.1101/2024.06.02.597051; URL: https://doi.org/10.1101/2024.06.02.597051 (davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6).

Embedded summary table
| Aspect | Summary | Key sources (with URLs where present) |
|---|---|---|
| Identity / Topology | Human MLEC (Malectin), UniProt Q14165 — type I membrane protein with a lumenal carbohydrate‑binding (malectin) domain, single transmembrane helix and short cytosolic tail. | Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354; Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201 |
| Domains / Family | Member of the malectin family (malectin_dom; IPR021720 / PF11721); highly conserved in animals. | Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354; Ringler 2020 (ringler2020structuralandfunctional pages 1-13) |
| Primary ligand specificity | Strong, selective recognition of di‑glucosylated high‑mannose N‑glycans (Glc2Man9GlcNAc2, “G2M9”); epitope centers on a Glcα1‑3Glc disaccharide; little binding to G1/G3 forms. | Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201; Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354 |
| Structural insights | X‑ray/biophysical data define a pocket that accommodates two glucose rings; key residues (e.g., S80, E102, Y104, Y131, D201) and structured water networks mediate high selectivity. | Ringler 2020 (ringler2020structuralandfunctional pages 38-42); Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354 |
| Cellular localization & dynamics | ER‑lumen resident, often concentrated in ER subdomains; steady‑state ER retention depends on ribophorin I (RPN1); ER stress (tunicamycin/thapsigargin) upregulates MLEC and can redistribute it toward Golgi when RPN1 is depleted. | Yang et al. 2018 (yang2018subcellulardistributionof pages 5-9, yang2018subcellulardistributionof pages 18-24) https://doi.org/10.1093/glycob/cwy034; Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201 |
| Interactors / Complexes | Forms complexes with ribophorin I (RPN1) and associates with misfolded glycoproteins; recent interactome/proteomics work reports association changes with OST components during coronavirus infection. | Yang et al. 2018 (yang2018subcellulardistributionof pages 5-9); Davies & Plate bioRxiv preprint (davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6) https://doi.org/10.1101/2024.06.02.597051; Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) |
| Functional role in pathways | Acts at an early step of ER glycoprotein quality control (ERQC) by recognizing the G2 glycoform prior to or upstream of the calnexin/calreticulin cycle; promotes retention and ER‑associated degradation (ERAD) of certain misfolded glycoproteins (e.g., ATNHK). | Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201; Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354 |
| Regulation (ER stress) | MLEC mRNA/protein is induced by ER stressors; RPN1 protein levels and MLEC:RPN1 balance regulate localization/function; overexpression of MLEC can enhance ERAD of selected misfolded clients. | Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201; Yang et al. 2018 (yang2018subcellulardistributionof pages 5-9) https://doi.org/10.1093/glycob/cwy034 |
| Disease / virus links | Implicated in viral glycoprotein biogenesis and shown in cell models to promote coronavirus replication (functional siRNA/proteomics evidence); flagged in proteomic biomarker screens (cancer studies). | Davies & Plate bioRxiv preprint (davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6) https://doi.org/10.1101/2024.06.02.597051; Schallus et al. 2008 (schallus2008malectinanovel pages 1-2) https://doi.org/10.1091/mbc.e08-04-0354 |
| Recent 2023–2024 findings | Functional proteomics/knockdown screens (2024 preprint) identify MLEC as a conserved ER proteostasis interactor required for efficient coronavirus glycoprotein production/replication; increased interest in MLEC's role within ERAD/OST networks. | Davies & Plate bioRxiv 2024 (davies2025theglycoproteinquality pages 1-4, davies2025theglycoproteinquality pages 4-6) https://doi.org/10.1101/2024.06.02.597051 |
| Quantitative data (affinity & expression) | Reported binding: Ka ≈ 1.97 × 10^5 M^-1 to G2M9 (Chen et al.); ITC Kd values for small disaccharides: nigerose ~26.3 ±7 μM, maltose ~50 μM, kojibiose ~210 μM (Ringler 2020). Functional: siRNA reduced MLEC protein ~80% in knockdown experiments and markedly decreased viral titers in MHV model (Davies preprint). | Chen et al. 2011 (chen2011roleofmalectin pages 1-2) https://doi.org/10.1091/mbc.e11-03-0201; Ringler 2020 (ringler2020structuralandfunctional pages 38-42); Davies 2024 (davies2025theglycoproteinquality pages 4-6) https://doi.org/10.1101/2024.06.02.597051 |

Table: Concise, evidence‑linked summary of key properties of human MLEC (UniProt Q14165), including identity, ligands, structure, localization, interactors, functional role in ER quality control, regulation by ER stress, disease/viral links, recent 2023–2024 findings, and quantitative data. Useful as a quick reference for experimental planning or functional annotation (sources cited by context IDs).

References

1. (schallus2008malectinanovel pages 1-2): Thomas Schallus, Christine Jaeckh, Krisztina Fehér, Angelina S. Palma, Yan Liu, Jeremy C. Simpson, Mukram Mackeen, Gunter Stier, Toby J. Gibson, Ten Feizi, Tomas Pieler, and Claudia Muhle-Goll. Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein n-glycosylation. Molecular biology of the cell, 19 8:3404-14, Aug 2008. URL: https://doi.org/10.1091/mbc.e08-04-0354, doi:10.1091/mbc.e08-04-0354. This article has 346 citations and is from a domain leading peer-reviewed journal.

2. (chen2011roleofmalectin pages 1-2): Yang Chen, Dan Hu, Rikio Yabe, Hiroaki Tateno, Sheng-Ying Qin, Naoki Matsumoto, Jun Hirabayashi, and Kazuo Yamamoto. Role of malectin in glc₂man₉glcnac₂-dependent quality control of α1-antitrypsin. Molecular Biology of the Cell, 22:3559-3570, Oct 2011. URL: https://doi.org/10.1091/mbc.e11-03-0201, doi:10.1091/mbc.e11-03-0201. This article has 75 citations and is from a domain leading peer-reviewed journal.

3. (ringler2020structuralandfunctional pages 1-13): LFA Ringler. Structural and functional characterization of the human malectin glycan-binding pocket. Unknown journal, 2020.

4. (ringler2020structuralandfunctional pages 38-42): LFA Ringler. Structural and functional characterization of the human malectin glycan-binding pocket. Unknown journal, 2020.

5. (yang2018subcellulardistributionof pages 5-9): Qin-Peng Yang, Ming-Fen Fu, Hao Gao, Kazuo Yamamoto, Dan Hu, and Sheng-Ying Qin. Subcellular distribution of endogenous malectin under rest and stress conditions is regulated by ribophorin i. Glycobiology, 28:374–381, Jun 2018. URL: https://doi.org/10.1093/glycob/cwy034, doi:10.1093/glycob/cwy034. This article has 14 citations and is from a peer-reviewed journal.

6. (yang2018subcellulardistributionof pages 1-5): Qin-Peng Yang, Ming-Fen Fu, Hao Gao, Kazuo Yamamoto, Dan Hu, and Sheng-Ying Qin. Subcellular distribution of endogenous malectin under rest and stress conditions is regulated by ribophorin i. Glycobiology, 28:374–381, Jun 2018. URL: https://doi.org/10.1093/glycob/cwy034, doi:10.1093/glycob/cwy034. This article has 14 citations and is from a peer-reviewed journal.

7. (d’alessio2015glucosidaseiiand pages 1-3): Cecilia D’Alessio and Nancy M. Dahms. Glucosidase ii and mrh-domain containing proteins in the secretory pathway. Current Protein & Peptide Science, 16:31-48, Feb 2015. URL: https://doi.org/10.2174/1389203716666150213160438, doi:10.2174/1389203716666150213160438. This article has 30 citations and is from a peer-reviewed journal.

8. (alonzi2017iminosugarantiviralsthe pages 1-3): Dominic S. Alonzi, Kathryn A. Scott, Raymond A. Dwek, and Nicole Zitzmann. Iminosugar antivirals: the therapeutic sweet spot. Biochemical Society Transactions, 45:571-582, Apr 2017. URL: https://doi.org/10.1042/bst20160182, doi:10.1042/bst20160182. This article has 132 citations and is from a peer-reviewed journal.

9. (davies2025theglycoproteinquality pages 1-4): Jonathan P. Davies and Lars Plate. The glycoprotein quality control factor malectin promotes coronavirus replication and viral protein biogenesis. bioRxiv, Jun 2025. URL: https://doi.org/10.1101/2024.06.02.597051, doi:10.1101/2024.06.02.597051. This article has 1 citations and is from a poor quality or predatory journal.

10. (davies2025theglycoproteinquality pages 4-6): Jonathan P. Davies and Lars Plate. The glycoprotein quality control factor malectin promotes coronavirus replication and viral protein biogenesis. bioRxiv, Jun 2025. URL: https://doi.org/10.1101/2024.06.02.597051, doi:10.1101/2024.06.02.597051. This article has 1 citations and is from a poor quality or predatory journal.

11. (yang2018subcellulardistributionof pages 18-24): Qin-Peng Yang, Ming-Fen Fu, Hao Gao, Kazuo Yamamoto, Dan Hu, and Sheng-Ying Qin. Subcellular distribution of endogenous malectin under rest and stress conditions is regulated by ribophorin i. Glycobiology, 28:374–381, Jun 2018. URL: https://doi.org/10.1093/glycob/cwy034, doi:10.1093/glycob/cwy034. This article has 14 citations and is from a peer-reviewed journal.

Citations

1. ringler2020structuralandfunctional pages 38-42
2. chen2011roleofmalectin pages 1-2
3. schallus2008malectinanovel pages 1-2
4. davies2025theglycoproteinquality pages 4-6
5. yang2018subcellulardistributionof pages 18-24
6. alonzi2017iminosugarantiviralsthe pages 1-3
7. ringler2020structuralandfunctional pages 1-13
8. yang2018subcellulardistributionof pages 5-9
9. yang2018subcellulardistributionof pages 1-5
10. davies2025theglycoproteinquality pages 1-4
11. https://doi.org/10.1101/2024.06.02.597051
12. https://doi.org/10.1091/mbc.e08-04-0354
13. https://doi.org/10.1091/mbc.e11-03-0201
14. https://doi.org/10.1093/glycob/cwy034
15. https://doi.org/10.2174/1389203716666150213160438
16. https://doi.org/10.1042/bst20160182
17. https://doi.org/10.1091/mbc.e08-04-0354;
18. https://doi.org/10.1091/mbc.e11-03-0201;
19. https://doi.org/10.1093/glycob/cwy034;
20. https://doi.org/10.1101/2024.06.02.597051;
21. https://doi.org/10.1091/mbc.e08-04-0354,
22. https://doi.org/10.1091/mbc.e11-03-0201,
23. https://doi.org/10.1093/glycob/cwy034,
24. https://doi.org/10.2174/1389203716666150213160438,
25. https://doi.org/10.1042/bst20160182,
26. https://doi.org/10.1101/2024.06.02.597051,

Malectin (MLEC) – Function and Recent Research

Key Concepts and Current Understanding

• Identity: Malectin (gene symbol MLEC) is a carbohydrate-binding lectin localized to the endoplasmic reticulum (ER) of human cells (www.ncbi.nlm.nih.gov). It is synthesized as a type I membrane-anchored glycoprotein, with a luminal malectin domain that binds specific N-linked sugars and a short cytosolic tail. The protein is highly conserved across animal species (first identified in Xenopus laevis) (pubmed.ncbi.nlm.nih.gov), and the human MLEC gene encodes a 292-amino-acid precursor that is processed into the mature ER protein (UniProt Q14165).

• Domain and Structure: The luminal domain of malectin defines a unique malectin family of lectins (Pfam PF11721). NMR structural studies (2008) showed this domain adopts a fold distinct from classic ER chaperones, with a pronounced binding pocket for glucose-based oligosaccharides (pmc.ncbi.nlm.nih.gov). Malectin’s structure is stabilized by multiple aromatic residues that mediate sugar binding, explaining its specificity for certain glycan epitopes (pmc.ncbi.nlm.nih.gov). Notably, malectin’s fold has similarity to some bacterial glycosidase domains, although malectin itself lacks enzymatic activity and functions purely as a sugar-binding protein (pubmed.ncbi.nlm.nih.gov).

• Glycan Binding Specificity: A hallmark of malectin is its high specificity for di-glucosylated N-glycans. It preferentially binds the N-linked oligosaccharide Glc₂Man₉GlcNAc₂ (a high-mannose glycan with two glucose residues) with measurable affinity (K_a ≈ 2×10^5 M^−1) (pubmed.ncbi.nlm.nih.gov). Malectin shows little to no binding to either the fully glucosylated Glc₃Man₉GlcNAc₂ or the monoglucosylated Glc₁Man₉GlcNAc₂ forms (pubmed.ncbi.nlm.nih.gov). This narrow specificity means malectin recognizes a transient intermediate in the N-glycosylation pathway that other ER lectins (like calnexin/calreticulin) do not.

• Role in Protein Folding QC: Malectin is now understood as a component of the ER’s glycoprotein quality control system. It selectively binds misfolded or folding-impaired glycoproteins that retain a Glc₂Man₉ glycan, effectively “tagging” these nascent glycoproteins for attention (pmc.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). By binding this glycan tag, malectin can delay further processing of the glycoprotein and facilitate its retention in the ER, preventing premature release of misfolded proteins. Malectin works in concert with other ER quality control factors, as detailed below.

• Interactions and Complexes: A key interacting partner of malectin is ribophorin I (RPN1), a subunit of the oligosaccharyltransferase (OST) complex embedded in the ER membrane (pmc.ncbi.nlm.nih.gov). Malectin constitutively associates with RPN1 (pmc.ncbi.nlm.nih.gov), which positions it at the site where new proteins enter the ER and receive N-glycans. RPN1 itself has been shown to selectively bind unfolded polypeptides and deliver them to the OST catalytic core (pmc.ncbi.nlm.nih.gov). This malectin–RPN1 complex effectively forms a link between glycan recognition and the detection of unfolded polypeptide regions. Such a complex allows malectin to tether misfolded glycoproteins at the translocon/OST site, flagging them for either refolding attempts or disposal. This mechanism is illustrated by findings that RPN1 preferentially interacts with misfolded model substrates (e.g. a mutant ribonuclease) but not the native form (pmc.ncbi.nlm.nih.gov), suggesting RPN1 acts as a chaperone for aberrant proteins. By partnering with RPN1, malectin helps create a checkpoint complex that recognizes both the sugar and protein-folding state of nascent glycoproteins (pmc.ncbi.nlm.nih.gov).

• Expression and Regulation: The MLEC gene is widely expressed in human tissues, consistent with its general role in protein folding. Transcript profiling shows ubiquitous expression, with notably high levels in secretory or metabolically active tissues (e.g. colon and thyroid, RPKM ~15–16) (www.ncbi.nlm.nih.gov). Importantly, malectin expression is upregulated by ER stress conditions. Under stress (e.g. treatment with tunicamycin or misfolded protein buildup), MLEC transcription is induced as part of the unfolded protein response (UPR) (pmc.ncbi.nlm.nih.gov). This induction is analogous to classic ER chaperones (like BiP or calnexin) and equips the cell with additional quality control capacity during proteotoxic stress. In fact, malectin is considered an ER stress-inducible lectin (www.omicsdi.org) (www.omicsdi.org). This regulatory pattern hints that malectin’s function becomes particularly crucial when the normal folding machinery is overwhelmed, as discussed below.

Malectin’s Role in ER Glycoprotein Quality Control

Malectin operates at the early stages of N-glycoprotein folding in the ER. The N-glycosylation pathway begins when the OST complex transfers a preassembled Glc₃Man₉GlcNAc₂ glycan onto nascent proteins. This 14-sugar precursor is then trimmed by ER glucosidases: first glucosidase I (GI) removes the outermost glucose, yielding a Glc₂Man₉GlcNAc₂ glycan (pmc.ncbi.nlm.nih.gov). It is at this point that malectin can bind. Under normal conditions, GI action is followed quickly by glucosidase II (GII) removing a second glucose to produce Glc₁Man₉GlcNAc₂ – the signal for calnexin/calreticulin binding in the classical folding cycle (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). However, if a glycoprotein is misfolded or the trimming by GII is delayed, the Glc₂Man₉ motif persists and becomes a binding target for malectin (pmc.ncbi.nlm.nih.gov).

Binding Step: Malectin’s high affinity for the di-glucosylated glycan allows it to capture glycoproteins in this intermediate state. Notably, malectin does not interfere with the initial engagement of calnexin – studies show it can bind glycoproteins without preventing their eventual entry into the calnexin cycle (www.omicsdi.org) (www.omicsdi.org). Instead, malectin seems to bind concurrently or prior to calnexin, possibly to a subset of glycoprotein molecules that are improperly folded. For example, experiments with influenza hemagglutinin (HA) (a model glycoprotein that normally requires calnexin) revealed that malectin and calnexin associate with HA at different times and prefer different conformers: malectin mainly binds misfolded forms of HA, whereas calnexin binds the folding-competent forms (www.omicsdi.org) (www.omicsdi.org). This suggests malectin provides an early screening of nascent chains, selecting those in trouble.

Retention and Folding Outcome: Once bound, malectin effectively holds the glycoprotein in the ER. Malectin binding has two documented consequences: (1) prolonged association with the client protein, and (2) interference with further N-glycan processing on that client (www.omicsdi.org). By covering the Glc₂Man₉ glycan, malectin may hinder glucosidase II or other processing enzymes, thereby freezing the glycan in a state that continues to signal “unfinished” folding. This is supported by biochemical data: malectin association correlates with persistent glycan trimming arrest and reduced trimming of glucose residues on misfolded glycoproteins (www.omicsdi.org). Such action prevents the misfolded protein from being passed along the secretory pathway. Instead, the protein remains in the ER where it can either attempt to refold (with help from chaperones) or be targeted to degradation if refolding fails.

Targeting to ERAD: Malectin appears to promote ER-associated degradation (ERAD) of irreparable glycoproteins. Overexpression studies provide strong evidence: when malectin is overexpressed in cells, secretion of a misfolded glycoprotein (the Null Hong Kong mutant of α₁-antitrypsin, a classic ERAD substrate) is dramatically inhibited, with most of the mutant protein being retained and eventually degraded in the ER (pubmed.ncbi.nlm.nih.gov). In contrast, the secretion of wild-type α₁-antitrypsin is largely unaffected by malectin overexpression (pubmed.ncbi.nlm.nih.gov). In one study, malectin almost completely blocked secretion of the mutant A1AT, whereas ~90% of the wild-type protein still secreted normally (pubmed.ncbi.nlm.nih.gov). This selective retention underscores malectin’s specificity for aberrant folding states. Mechanistically, malectin does not itself possess degradative activity, but by holding the client in the ER and perhaps recruiting other factors, it promotes routing of the client to the ERAD pathway (which involves retro-translocation to the cytosol and proteasomal degradation).

Cooperation with Calnexin System: Malectin’s role is often described as a “backup” quality control pathway alongside the calnexin/calreticulin system (pmc.ncbi.nlm.nih.gov) (www.omicsdi.org). Galli et al. (2011) first coined this term, showing that malectin’s intervention becomes critical under stress conditions when the normal calnexin cycle might be overwhelmed (www.omicsdi.org). Under ER stress (e.g., UPR activation), malectin levels rise and it increasingly engages misfolded cargos. This backup pathway ensures that misfolded glycoproteins are not lost even if the calnexin cycle can’t handle them all. In practical terms, malectin and calnexin recognize different signals (Glc₂ vs. Glc₁ glycans) and can bind the same client sequentially or in parallel. A misfolded glycoprotein might cycle between calnexin (after one glucose trim) and, if it undergoes reglucosylation by UDP-glucose:glycoprotein glucosyltransferase (UGGT), it could re-enter calnexin; malectin provides an additional layer, capturing those glycoproteins that expose the uncommon Glc₂ tag due to incomplete trimming (pmc.ncbi.nlm.nih.gov). This layer is particularly relevant if GII activity is impaired or slow (such as during stress or if the substrate is misfolded), causing an accumulation of Glc₂-glycans.

Malectin–RPN1 Quality Control Complex: As noted, malectin partners with RPN1 on the ER membrane. This partnership is thought to couple glycan-based recognition (by malectin) with polypeptide-based recognition (by RPN1). RPN1’s luminal domain can bind exposed hydrophobic patches of unfolding proteins (pmc.ncbi.nlm.nih.gov), acting similarly to a chaperone. Meanwhile, malectin binds the glycan moiety of the same protein. This dual binding secures the misfolded glycoprotein at the translocon or OST site, preventing its forward trafficking. Researchers have proposed a model where the malectin–RPN1 complex loads misfolded glycoproteins into the ERAD pathway: RPN1 holds the client protein at the membrane, and malectin keeps it glycosylated (by blocking trimming) until an ERAD ubiquitin ligase complex (such as SEL1L-HRD1) can recognize and retro-translocate the client for degradation (pmc.ncbi.nlm.nih.gov). In summary, malectin acts as a specialized sensor for glycoprotein folding status, ensuring that only properly folded glycoproteins advance, while faulty ones are retained and disposed of.

Recent Developments (2023–2024)

Recent research has shed light on malectin’s importance in specific physiological and pathological contexts, underlining its broad relevance beyond basic cell biology. Below are two key areas of development:

Malectin in Viral Infections (Coronavirus)

New studies during the COVID-19 pandemic have identified malectin as a host factor exploited by coronaviruses (CoVs). In 2024, Jonathan Davies et al. used proteomic screens to find host proteins interacting with SARS-CoV-2 and other CoV proteins. They discovered that malectin (MLEC) consistently interacts with viral non-structural proteins in the ER and plays a pro-viral role in infection (pmc.ncbi.nlm.nih.gov). Knockdown of MLEC in human cells had a striking effect: it significantly reduced the production of infectious virus particles (lowering viral titers) (pmc.ncbi.nlm.nih.gov). This implies that viruses like SARS-CoV-2 rely on the malectin-mediated quality control mechanism for efficient folding or stability of their own glycoproteins. Indeed, CoV spike proteins and certain other viral proteins are heavily glycosylated and fold in the host ER; malectin may help retain these viral glycoproteins until they fold properly, thereby increasing viral protein yield.

Mechanistically, during coronavirus infection malectin’s interaction network in the cell is altered but notably it retains association with the OST complex (pmc.ncbi.nlm.nih.gov). The OST complex is crucial for adding glycans to viral proteins, so malectin staying engaged with OST suggests it helps maximize glycosylation and proper folding of viral glycoproteins. The same study showed malectin promotes viral protein accumulation and viral genome replication in infected cells (pmc.ncbi.nlm.nih.gov). In functional terms, without malectin, misfolded viral glycoproteins might be degraded faster or not achieve the conformations needed for virus assembly, leading to attenuated infection. Conversely, malectin presence supports the biogenesis of viral proteins, making infection more efficient. Importantly, this research (published as a preprint in 2024 and in peer review in 2025) proposes that malectin could be a target for broad-spectrum antiviral therapy (pmc.ncbi.nlm.nih.gov). Since malectin is a host factor, a drug that modulates malectin’s activity or expression might impair the replication of multiple coronaviruses (a “pan-CoV” strategy) without the virus easily mutating resistance. While such interventions are still speculative, this finding underscores malectin’s critical role in the ER proteostasis hijacked by viruses.

Malectin in Cancer (Hepatocellular Carcinoma)

Another emerging area is malectin’s involvement in cancer cell survival and aggressiveness, particularly under conditions of ER stress common in tumors. A 2025 study by Dong Yu et al. examined hepatocellular carcinoma (HCC) and found malectin abnormally overexpressed in tumor tissues and cell lines compared to normal liver (academic.oup.com). Because solid tumors often experience hypoxia and nutrient deprivation, they activate the UPR and upregulate ER stress proteins to cope; malectin appears to be one such protein. The study reported that malectin expression is significantly up-regulated in HCC, and this correlates with the tumor’s ability to handle misfolded protein load (academic.oup.com).

Functionally, knocking out MLEC in HCC cells attenuated malignant behaviors. CRISPR-Cas9 deletion of malectin in two human HCC cell lines did not reduce their baseline proliferation, but it led to markedly decreased colony formation, migration, and invasion in vitro (academic.oup.com). In other words, malectin-null HCC cells grew normally under non-stressful conditions but failed to thrive when challenged (e.g. forming colonies in soft agar or migrating through membranes). Moreover, in an in vivo xenograft model, HCC cells lacking malectin formed smaller tumors in mice, with significantly slower tumor growth than malectin-expressing control cells (academic.oup.com). These findings suggest that malectin endows cancer cells with an advantage in handling ER stress or proteome imbalances that occur during rapid tumor growth. By trapping misfolded proteins and preventing proteotoxic stress, malectin may help tumor cells survive and continue proliferating under harsh conditions. Thus, malectin appears to have an “oncogenic” role in HCC progression (academic.oup.com), insofar as it facilitates the traits of cancer aggressiveness (invasion, growth). This raises the possibility that malectin could be explored as a therapeutic target or biomarker in cancers that rely on a high capacity for protein folding quality control. If a tumor is “addicted” to malectin for survival under ER stress, then inhibiting malectin might selectively impair the tumor while sparing normal cells (which have lower stress levels and redundant QC pathways).

Other Disease Associations

While less studied than viruses and cancer, malectin has also been implicated in immune and developmental conditions. One genetic association study (2018) linked MLEC polymorphisms to cerebral palsy, proposing that certain variants of malectin might influence neonatal brain injury via immune modulation (www.ncbi.nlm.nih.gov). The authors suggested malectin variants could skew macrophage polarization toward an M2-like phenotype, potentially affecting inflammation in the developing brain. Although the exact mechanism is not fully elucidated, this finding hints that malectin’s activity in glycoprotein processing might impact immune cell function or secretion of cytokines. It is an area warranting further research. More broadly, these insights reflect a growing recognition that malectin’s role in ER homeostasis can have downstream effects on various physiological processes and diseases.

Current Applications and Real-World Implementations

Given malectin’s role in quality control, several practical applications and research tools have emerged:

• Research and Diagnostic Tools: Malectin protein and antibodies are available for experimental use. For instance, recombinant human malectin is sold for in vitro binding assays or structural studies (www.abcam.com), and anti-malectin antibodies are used in Western blots and immunohistochemistry to detect malectin levels in cells or tissues (www.antibodies-online.com). Additionally, ELISA kits (including for model organisms) exist to quantify malectin, reflecting interest in malectin as a biomarker (www.mybiosource.com). In research, fluorescently tagged malectin is sometimes used to monitor ER quality control capacity or to pull down glycoprotein clients for analysis (pmc.ncbi.nlm.nih.gov).

• Therapeutic Target Potential: As noted, malectin is being explored as a potential drug target in antiviral therapy. The reasoning is that a drug that inhibits malectin’s function might selectively disrupt the life cycle of viruses (like SARS-CoV-2) that depend on host ER folding pathways (pmc.ncbi.nlm.nih.gov). Such antivirals would operate by inducing misfolding stress on viral glycoproteins, thereby reducing virus viability. This approach is still in the preclinical stage, but it represents a novel host-directed antiviral strategy. Similarly, in oncology, malectin could be a target for anti-cancer therapy or a prognostic marker. For example, if high malectin expression correlates with poor prognosis in HCC or other cancers, malectin levels might guide treatment decisions or inspire combination therapies (e.g., UPR inhibitors). Some researchers have proposed screening for small molecules that modulate malectin’s lectin activity or expression as a way to sensitize cancer cells to ER stress-induced death. However, no malectin-targeted drugs are in clinical trials yet, and any such intervention would need to balance the potential toxicity of impairing a fundamental ER function.

• Biotechnology: Malectin’s binding specificity for a defined glycan structure has been leveraged in glyco-engineering and analytical chemistry. The protein can serve as a lectin probe to detect Glc₂-bearing glycans on glycoproteins. For instance, scientists have used malectin in lectin microarray platforms to identify glycoproteins that exit the ER prematurely with abnormal glycosylation patterns (www.omicsdi.org). Malectin pulldown assays can enrich for client proteins that are substrates of ER quality control, aiding in the discovery of factors involved in diseases of protein misfolding (like certain storage diseases or mutant insulin in diabetes). Its unique sugar-binding property complements other lectins (like concanavalin A or calnexin) to give a more complete picture of glycan states on proteins.

• Gene Editing Models: To study malectin function, researchers have created Mlec knockout mice and cell lines. Mouse models (e.g., conditional Mlec knockouts) are being used to investigate malectin’s role in vivo – for example, in B cell antibody secretion or metabolic stress during disease (www.genoway.com). Preliminary reports suggest that while malectin knockout mice are viable (implying redundancy in ER QC), they may show subtle phenotypes under stress conditions (such as heightened sensitivity to ER stress in certain cell types). These models are valuable for testing how malectin loss impacts pathological processes like liver injury or neurological development.

In summary, malectin’s distinct position at the crossroads of glycoprotein folding and quality control is driving diverse real-world investigations – from improving our understanding of viral infection mechanisms to identifying novel approaches for cancer treatment.

Expert Opinions and Analysis

Malectin has attracted considerable interest in the cell biology community since its discovery, and experts have offered insights into its function within the broader proteostasis network:

• Backup Quality Control Perspective: Glycobiology experts (e.g. Maurizio Molinari and colleagues) describe malectin as a “backup” lectin in the ER that supplements the calnexin/calreticulin system (www.omicsdi.org). In their 2011 analysis, Galli et al. observed that inducing malectin (to mimic UPR conditions) caused malectin to stably engage misfolded glycoproteins and block their secretion (www.omicsdi.org). They proposed a model wherein “malectin intervention is activated upon ER stress to inhibit secretion of defective gene products that might be generated under conditions of aberrant functioning of the ER quality control machinery” (www.omicsdi.org). This expert view highlights malectin’s role as a failsafe mechanism: when the normal QC machinery is overwhelmed, malectin helps prevent potentially harmful, misfolded proteins from leaving the ER. This idea has been influential in guiding subsequent research on malectin, framing it as part of the cellular stress-response toolkit.

• Integration into ER Quality Control Models: By 2014, malectin was being formally incorporated into reviews of ER protein folding. Kazuo Yamamoto’s group, for example, outlined how malectin, calnexin, and ER glucosidase IIβ work together in the folding of new glycoproteins (pmc.ncbi.nlm.nih.gov). They noted malectin’s unique sugar specificity and its inducibility under stress, concluding that malectin assists nascent folding alongside classical chaperones (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Their model suggests that malectin provides an early checkpoint (binding Glc₂-glycans) before calnexin acts, thus enriching the QA/QC network. The consistent theme in expert analyses is that malectin enhances the fidelity of protein folding – effectively reducing the burden of misfolded proteins that reach the Golgi or cell surface (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This consensus underscores malectin’s importance: while not essential under normal conditions, it becomes critical for maintaining protein homeostasis under stress or for certain difficult-to-fold proteins.

• Disease Relevance: Experts in virology and oncology have also commented on malectin’s emerging significance. Virologists note that malectin’s pro-viral role is a double-edged sword – it reflects how adept viruses are at co-opting host pathways, but it also highlights malectin as a potential “Achilles’ heel” of viral replication (pmc.ncbi.nlm.nih.gov). For instance, Lars Plate (co-author of the 2024 coronavirus study) noted that inhibiting malectin could suppress coronavirus replication broadly, an insight aligning with the expert notion of targeting host chaperones in antiviral therapy (pmc.ncbi.nlm.nih.gov). On the cancer side, oncologists find the HCC results intriguing, as they align with the broader concept that the UPR and ER quality control support tumor survival. Some have posited that malectin overexpression in tumors could be part of an adaptive response enabling tumor cells to handle the high secretory load and hypoxic stress. Therefore, leading researchers suggest malectin might serve as a biomarker for tumors under high ER stress, and potentially a target to push cancer cells over the edge into lethal stress. These expert opinions remain to be tested in clinical settings, but they underscore a growing appreciation that malectin is more than a housekeeping protein – it’s a node where protein folding, stress response, and disease pathways intersect.

• Quantitative Insights: Authoritative sources also provide quantitative context to malectin’s activity. For example, the binding affinity of malectin for Glc₂Man₉GlcNAc₂ (on the order of 10^5 M^−1) is considered relatively low, indicating transient interactions characteristic of lectin-chaperones (pmc.ncbi.nlm.nih.gov). Experts interpret this weak affinity as biologically sensible: it allows malectin to bind and release clients dynamically (necessary for iterative folding attempts), rather than irreversibly trapping them. Additionally, the fact that malectin’s affinity is much lower than typical antibody-antigen interactions (K_a ~10^7–10^9) is often cited as an example of how lectins use multivalency or teamwork to achieve effective retention (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In cells, malectin likely works in tandem with other ER factors or oligomerizes to increase avidity for misfolded substrates. This view is supported by the co-localization with OST and possibly oligomeric behavior (malectin has a tendency to form dimers in some experimental systems, though this is not yet fully characterized).

In conclusion, malectin (MLEC) is recognized by experts as a crucial ER lectin that safeguards the fidelity of protein folding. Its ability to bind a specific glycan marker on nascent glycoproteins, and its inducible nature, make it a dynamic regulator of proteostasis. Our current understanding – enriched by recent research – paints malectin as a versatile player: ensuring proper protein quality control under stress, aiding in certain pathogenic processes (viruses, cancer), and offering novel angles for therapeutic intervention. As research continues (with studies as recent as 2024–2025), malectin stands out as a prime example of how a deep basic-science understanding of protein folding can illuminate new frontiers in medicine and biotechnology.

References (with publication year and source):

1. Chen et al., 2011 – Mol. Biol. Cell 22(19):3559-3570. PMID: 21813736. “Role of malectin in Glc₂Man₉GlcNAc₂-dependent quality control of α1-antitrypsin.” (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov)

2. Qin et al., 2012 – J. Biol. Chem. 287(46):38080-38089. PMID: 22977249. “Malectin forms a complex with ribophorin I for enhanced association with misfolded glycoproteins.” (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

3. Galli et al., 2011 – PLoS ONE 6(1):e16304. PMID: 21298140. “Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER.” (www.omicsdi.org) (www.omicsdi.org)

4. Yamamoto, 2014 – Proc. Jpn. Acad. Ser. B 90(2):67-82. PMID: 24522156. “Intracellular lectins are involved in quality control of glycoproteins.” (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov)

5. Davies & Plate et al., 2024 – bioRxiv preprint (later in eLife 2025). “The glycoprotein quality control factor malectin promotes coronavirus replication and viral protein biogenesis.” (pmc.ncbi.nlm.nih.gov)

6. Yu et al., 2025 – Glycobiology 35(4):357-368. PMID: 39987555. “Malectin, an ER-resident lectin, promotes malignant behavior of human hepatocellular carcinoma.” (academic.oup.com)

7. Shi et al., 2018 – Clin. Genet. 93(4):839-848. PMID: 28972276. “Malectin gene polymorphisms promote cerebral palsy via M2-like macrophage polarization.” (www.ncbi.nlm.nih.gov)

Citations

1. AnnotationURLCitation(end_index=390, start_index=233, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=This%20gene%20encodes%20the%20carbohydrate,Expression')
2. AnnotationURLCitation(end_index=833, start_index=650, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before')
3. AnnotationURLCitation(end_index=1405, start_index=1249, title='Malectin: A Novel Carbohydrate-binding Protein of the Endoplasmic Reticulum and a Candidate Player in the Early Steps of Protein N-Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=glycoprotein%20folding%20and%20quality%20control,glycosylated%20proteins')
4. AnnotationURLCitation(end_index=1718, start_index=1555, title='Malectin: A Novel Carbohydrate-binding Protein of the Endoplasmic Reticulum and a Candidate Player in the Early Steps of Protein N-Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2488313/#:~:text=Structure%20of%20the%20main%20domain,and%20D186%20mediating%20the%20interaction')
5. AnnotationURLCitation(end_index=2084, start_index=1901, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Malectin%20was%20first%20discovered%20as,immunoprecipitation%20experiments%20demonstrate%20that%20before')
6. AnnotationURLCitation(end_index=2500, start_index=2371, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type')
7. AnnotationURLCitation(end_index=2774, start_index=2645, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,type')
8. AnnotationURLCitation(end_index=3417, start_index=3240, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
9. AnnotationURLCitation(end_index=3601, start_index=3418, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
10. AnnotationURLCitation(end_index=4207, start_index=4055, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
11. AnnotationURLCitation(end_index=4410, start_index=4258, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
12. AnnotationURLCitation(end_index=4762, start_index=4610, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=analysis%20of%20proteins%20that%20co,Molecular%20modeling%20of%20the')
13. AnnotationURLCitation(end_index=5348, start_index=5210, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
14. AnnotationURLCitation(end_index=5707, start_index=5565, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5')
15. AnnotationURLCitation(end_index=6204, start_index=6010, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=Expression%20Ubiquitous%20expression%20in%20colon,other%20tissues%20See%20more%20Orthologs')
16. AnnotationURLCitation(end_index=6616, start_index=6439, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
17. AnnotationURLCitation(end_index=7035, start_index=6848, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=ABSTRACT%3A%20Malectin%20is%20a%20conserved%2C,revealed%20that%20induction%20of%20Malectin')
18. AnnotationURLCitation(end_index=7200, start_index=7036, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
19. AnnotationURLCitation(end_index=7876, start_index=7772, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further')
20. AnnotationURLCitation(end_index=8244, start_index=8140, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=The%20N,We%20further')
21. AnnotationURLCitation(end_index=8408, start_index=8245, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=When%20the%20terminal%20%CE%B11%2C3,sugar%20moieties%20of%20unfolded%20proteins')
22. AnnotationURLCitation(end_index=8713, start_index=8559, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
23. AnnotationURLCitation(end_index=9150, start_index=9042, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
24. AnnotationURLCitation(end_index=9315, start_index=9151, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
25. AnnotationURLCitation(end_index=9891, start_index=9783, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
26. AnnotationURLCitation(end_index=10056, start_index=9892, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
27. AnnotationURLCitation(end_index=10609, start_index=10445, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
28. AnnotationURLCitation(end_index=11142, start_index=10978, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
29. AnnotationURLCitation(end_index=12000, start_index=11817, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
30. AnnotationURLCitation(end_index=12289, start_index=12106, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
31. AnnotationURLCitation(end_index=12615, start_index=12432, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
32. AnnotationURLCitation(end_index=13234, start_index=13146, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=,DOI')
33. AnnotationURLCitation(end_index=13414, start_index=13235, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
34. AnnotationURLCitation(end_index=13756, start_index=13592, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
35. AnnotationURLCitation(end_index=14629, start_index=14475, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
36. AnnotationURLCitation(end_index=15255, start_index=15117, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
37. AnnotationURLCitation(end_index=15966, start_index=15824, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Interestingly%2C%20we%20demonstrated%20that%20ribophorin,5')
38. AnnotationURLCitation(end_index=17036, start_index=16857, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=proteomics%20and%20functional%20genetic%20screening%2C,Lastly%2C%20we%20show%20MLEC%20promotes')
39. AnnotationURLCitation(end_index=17336, start_index=17192, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
40. AnnotationURLCitation(end_index=18031, start_index=17887, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
41. AnnotationURLCitation(end_index=18481, start_index=18337, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
42. AnnotationURLCitation(end_index=19078, start_index=18946, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
43. AnnotationURLCitation(end_index=19994, start_index=19822, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using')
44. AnnotationURLCitation(end_index=20510, start_index=20338, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=Accumulating%20evidences%20have%20shown%20that,7703%20using')
45. AnnotationURLCitation(end_index=20983, start_index=20792, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
46. AnnotationURLCitation(end_index=21550, start_index=21359, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
47. AnnotationURLCitation(end_index=22130, start_index=21939, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=expression%20is%20aberrantly%20up,in%20HCC%20tumorigenesis%20and%20development')
48. AnnotationURLCitation(end_index=23078, start_index=22947, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free')
49. AnnotationURLCitation(end_index=24224, start_index=24024, title='Recombinant Human Malectin protein (ab167903) | Abcam', type='url_citation', url='https://www.abcam.com/en-us/products/proteins-peptides/recombinant-human-malectin-protein-ab167903#:~:text=JavaScript%20is%20disabled%20in%20your,protein%20is%20a%20Human%20Fragment')
50. AnnotationURLCitation(end_index=24506, start_index=24356, title='Malectin Antibody (ABIN2855260)', type='url_citation', url='https://www.antibodies-online.com/antibody/2855260/anti-Malectin+MLEC+antibody/#:~:text=Malectin%20Antibody%20,Malectin')
51. AnnotationURLCitation(end_index=24785, start_index=24640, title='MLEC elisa kit | Cavy Malectin (MLEC) ELISA Kit-Q14165', type='url_citation', url='https://www.mybiosource.com/cavy-elisa-kits/malectin-mlec/9923552#:~:text=MLEC%20elisa%20kit%20,MLEC%29%2C%20ELISA%20Kit')
52. AnnotationURLCitation(end_index=25049, start_index=24937, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=Coronaviruses%20,associated')
53. AnnotationURLCitation(end_index=25483, start_index=25351, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
54. AnnotationURLCitation(end_index=26893, start_index=26785, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
55. AnnotationURLCitation(end_index=27768, start_index=27592, title='Mlec conditional Knockout mouse | Studied in ER protein folding and glycoprotein processing | genOway', type='url_citation', url='https://www.genoway.com/product/knockout-mouse-models/mlec#:~:text=Mlec%20conditional%20Knockout%20mouse%20,Mlec%20conditional%20Knockout%20mouse%20Contact')
56. AnnotationURLCitation(end_index=29011, start_index=28832, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
57. AnnotationURLCitation(end_index=29357, start_index=29193, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
58. AnnotationURLCitation(end_index=29775, start_index=29596, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=association%20between%20the%20ER%20lectin,the%20ER%20quality%20control%20machinery')
59. AnnotationURLCitation(end_index=30533, start_index=30394, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=4,malectin%2C%20calnexin%20and%20glucosidase%20II%CE%B2')
60. AnnotationURLCitation(end_index=30806, start_index=30701, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT')
61. AnnotationURLCitation(end_index=30984, start_index=30807, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
62. AnnotationURLCitation(end_index=31451, start_index=31322, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=Glc_,reduced%20secretion%20of%20these%20cargo')
63. AnnotationURLCitation(end_index=31588, start_index=31452, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that')
64. AnnotationURLCitation(end_index=32270, start_index=32138, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=titers%20when%20knocked%20down,CoV%20antivirals')
65. AnnotationURLCitation(end_index=32655, start_index=32511, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
66. AnnotationURLCitation(end_index=33890, start_index=33736, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=a%20novel%20membrane,Malectin%20preferentially%20associated%20with%20a')
67. AnnotationURLCitation(end_index=34489, start_index=34328, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=folding%20of%20nascent%20glycoproteins%2C%20ER,glycans%20are%20trimmed%20into')
68. AnnotationURLCitation(end_index=34652, start_index=34490, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=degradation%20via%20ubiquitination.,association%20mechanisms%20such%20as%20the')
69. AnnotationURLCitation(end_index=36100, start_index=35963, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=quality%20control%2C%20malectin%20is%20highly,Q3%29%20dose')
70. AnnotationURLCitation(end_index=36284, start_index=36101, title='Role of malectin in Glc(2)Man(9)GlcNAc(2)-dependent quality control of α1-antitrypsin - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21813736/#:~:text=Metabolic%20labeling%20and%20immunoprecipitation%20experiments,induced%20by%20tunicamycin%20results%20in')
71. AnnotationURLCitation(end_index=36606, start_index=36470, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=proteins.,the%20native%20form%2C%20suggesting%20that')
72. AnnotationURLCitation(end_index=36745, start_index=36607, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=OST%20complex.,complex%20with%20ribophorin%20I%2C%20as')
73. AnnotationURLCitation(end_index=37021, start_index=36913, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=residues,We')
74. AnnotationURLCitation(end_index=37186, start_index=37022, title='S-EPMC3027649 - Malectin participates in a backup glycoprotein quality control pathway in the mammalian ER. - OmicsDI', type='url_citation', url='https://www.omicsdi.org/dataset/biostudies-literature/S-EPMC3027649#:~:text=clients%20NHK%20and%20%3F1,the%20ER%20quality%20control%20machinery')
75. AnnotationURLCitation(end_index=37448, start_index=37343, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=membrane,type%20%28WT')
76. AnnotationURLCitation(end_index=37626, start_index=37449, title='Intracellular lectins are involved in quality control of glycoproteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3948941/#:~:text=demonstrated%20that%20like%20other%20molecular,molecular%20mechanisms%20by%20which%20malectin')
77. AnnotationURLCitation(end_index=37967, start_index=37823, title='The glycoprotein quality control factor Malectin promotes coronavirus replication and viral protein biogenesis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11185542/#:~:text=murine%20hepatitis%20virus%20%E2%80%93%20a,CoV%20antivirals')
78. AnnotationURLCitation(end_index=38316, start_index=38142, title='Malectin, an endoplasmic reticulum-resident lectin, promotes malignant behavior of human hepatocellular carcinoma | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/advance-article/doi/10.1093/glycob/cwaf007/8030605#:~:text=%28ER%29%20stress%20conditions,HCC%20cells%20in%20nude%20mice')
79. AnnotationURLCitation(end_index=38615, start_index=38484, title='MLEC malectin [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=9761#:~:text=1,PMID%2021813736%2C%20Free')